- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Bangladesh to get Indian COVID-19 vaccine on priority, says Harsh Vardhan Shringla
Shringla met Bangladeshi Prime Minister Sheikh Hasina on Tuesday during which they discussed ways to co-operate on containing the coronavirus pandemic, including on therapeutics and vaccine, sources said.
Dhaka [Bangladesh]: Bangladesh will be a priority recipient for the Covid-19 vaccine developed in India according to foreign secretary Harsh Vardhan Shringla.
"For us, Bangladesh is always a priority country," Shringla who is on a two-day visit here quoted by local media as telling reporters here on Wednesday on being asked about the vaccines.
Dhaka today said it is ready to hold trials of the potential Covid-19 vaccines being developed by India.
The proposal was made during a meeting between Shringla and his Bangladesh counterpart Masud Bin Momen at Hotel Sonargaon here.
"We offered that we can extend our assistance, if needed, especially in terms of a vaccine trial, we are ready," Bangladesh's Daily Star quoted Momen as saying.
Momen said that the Indian side positively responded, saying that they are developing vaccines not only for themselves but also for others and that Bangladesh will get priority.
Momen also said that Bangladesh has a good number of pharmaceutical companies with the capacity of vaccine production.
"We sought their cooperation in creating collaboration to that end," he said.
Clinical trials of two COVID-19 vaccines developed in India are underway.
The Phase-2 human clinical trials of two COVID-19 vaccines developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd are currently underway in India.
Shringla met Bangladeshi Prime Minister Sheikh Hasina on Tuesday during which they discussed ways to co-operate on containing the coronavirus pandemic, including on therapeutics and vaccine, sources said.
Shringla is on his two-day visit to Bangladesh. He reached Dhaka on Tuesday in his first foreign visit since the COVID-19 pandemic outbreak.
coronavirus vaccinecovid-19coronavirusharsh vardhan shringlabharat biotechzydus cadilasheikh hasinaicmr
Source : ANIRuchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story